losartan has been researched along with interleukin-8 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daniel, WG; Eskafi, S; Gabler, C; Garlichs, CD; Illmer, T; Lorenz, HM; Roerick, O; Schmeisser, A; Soehnlein, O; Strasser, R | 1 |
| Chen, MF; Li, YJ; Luo, BL; Wang, YJ; Xie, XM; Yang, TL; Zhang, XH | 1 |
| Axelsson, J; Ayala, ER; Lindholm, B; Qian, JQ; Stenvinkel, P; Yao, Q | 1 |
| Choi, HC; Kang, YJ; Kim, HS; Kim, HY; Song, IH | 1 |
| Chen, MF; Li, YJ; Lou, B; Xie, XM; Yang, TL | 1 |
| Asadikaram, G; Ebrahimi, N; Kazemi Arababadi, M; Kiani, Z; Kohan, F; Masoumi, M; Nasiri, AA; Sepehri, Z; Sheikh Fathollahi, M | 1 |
6 other study(ies) available for losartan and interleukin-8
| Article | Year |
|---|---|
ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cell Line; Chemokine CCL2; Chemokines; Down-Regulation; Drug Interactions; Endothelium, Vascular; Humans; Imidazoles; Interleukin-8; Losartan; Monocytes; NF-kappa B; Peptidyl-Dipeptidase A; Pyridines; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Simvastatin; Umbilical Veins | 2004 |
Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II.
Topics: Amidohydrolases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arginine; Cell Adhesion; Cells, Cultured; Culture Media, Conditioned; Endothelial Cells; Endothelium, Vascular; Gene Expression Regulation; Humans; Interleukin-8; Losartan; Monocytes; NF-kappa B; Nitrates; Nitric Oxide; Nitrites; Protein-Arginine N-Methyltransferases; Reactive Oxygen Species; Receptors, Interleukin-8B; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Umbilical Veins; Vasculitis; Vasodilation | 2007 |
A combination of a PPAR-gamma agonist and an angiotensin II receptor blocker attenuates proinflammatory signaling and stimulates expression of Smad7 in human peritoneal mesothelial cells.
Topics: Angiotensin Receptor Antagonists; Cells, Cultured; Epithelium; Glucose; Humans; Inflammation Mediators; Interleukin-6; Interleukin-8; Losartan; Peritoneum; PPAR gamma; Rosiglitazone; Signal Transduction; Smad7 Protein; Thiazolidinediones; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2007 |
Upregulation of interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cells, Cultured; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Heme Oxygenase-1; Hypertension; Interleukin-8; Losartan; Male; Muscle, Smooth, Vascular; NF-kappa B; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Signal Transduction; Transfection; Up-Regulation; Vasoconstrictor Agents | 2008 |
Losartan inhibits monocytic adhesion induced by ADMA via downregulation of chemokine receptors in monocytes.
Topics: Arginine; Cell Adhesion; Cells, Cultured; Chemokine CCL2; Dose-Response Relationship, Drug; Down-Regulation; Endothelial Cells; Humans; Interleukin-8; Losartan; Monocytes; NF-kappa B; Receptors, Chemokine; RNA, Messenger; Time Factors | 2009 |
Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension.
Topics: Antihypertensive Agents; Atorvastatin; Captopril; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Inflammation; Interleukin-6; Interleukin-8; Iran; Losartan; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Up-Regulation | 2016 |